Bilateral response after unilateral subconjunctival bevacizumab injection in a child with Stevens-Johnson syndrome

Bevacizumab is widely used for several ocular conditions, including age-related macular degeneration, diabetic retinopathy, corneal neovascularization, neovascular glaucoma, and retinopathy of prematurity. We describe a 14-year-old patient with Stevens-Johnson syndrome in whom subconjunctival inject...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of AAPOS 2012-06, Vol.16 (3), p.309-311
Hauptverfasser:	Kesarwani, Siddharth, MS, Sahu, Srikant Kumar, MS, Basu, Soumyava, MS
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Angiogenesis Inhibitors - administration & dosage Antibodies, Monoclonal, Humanized - administration & dosage Bevacizumab Conjunctiva - drug effects Corneal Neovascularization - drug therapy Corneal Neovascularization - etiology Humans Injections, Intraocular Male Ophthalmology Stevens-Johnson Syndrome - complications Vascular Endothelial Growth Factor A - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Bevacizumab is widely used for several ocular conditions, including age-related macular degeneration, diabetic retinopathy, corneal neovascularization, neovascular glaucoma, and retinopathy of prematurity. We describe a 14-year-old patient with Stevens-Johnson syndrome in whom subconjunctival injection of bevacizumab in one eye caused bilateral regression of corneal neovascularization.
ISSN:	1091-8531 1528-3933
DOI:	10.1016/j.jaapos.2011.12.153